CIMT 2019 Annual Meeting

May 21-23, 2019

Rheingoldhalle Congress Center Mainz, Germany

Every year, the CIMT Annual Meeting connects the global cancer immunotherapy community in the heart of Europe. As the largest meeting focused on cancer immunotherapy research and development in Europe, CIMT 2019 invites international participants for high-level scientific exchange, collaboration, and education focused on cancer immunotherapy.

For 2019, the CIMT program committee is preparing plenary sessions from pre-clinical research to clinical development on the topics of neoantigens, cellular therapy, improving immunity, tumor microenvironment, regulatory research and immunoguiding. The plenary sessions will be complemented by a poster exhibit and selected poster short talk sessions, as well as industry symposia and industry exhibits.

At the meeting, all poster entries will be judged by an international judging panel to select the 2019 Poster Award winners who will be announced at the CIMT Social Event on May 22.

CIMT also offers young scientists from underrepresented countries travel awards of up to 1000 EUR plus free conference admission to offset meeting-related expenses.
Travel awards can only be issued to scientists who have submitted an abstract and are registered to attend the meeting. Please go to http://www.meeting.cimt.eu/call_for_abstracts for more information.

2019 Scientific Planning Committee

Mustafa Diken
TRON-Translational Oncology, Mainz/Germany; CIMT Scientific Secretary

Harpreet Singh
immatics Biotechnologies, Tübingen/Germany

Sine Reker Hadrup
Denmark Technical University, Copenhagen/Denmark

Marij Welters
Leiden University Medical Center, Leiden/The Netherlands

Sebastian Kreiter
TRON-Translational Oncology, Mainz/Germany; Head CIMT Management Board

Carl Figdor
Radboud University, Nijmegen/The Netherlands

Kees Melief
ISA Pharmaceuticals, Leiden/The Netherlands

Özlem Türeci
BioNTech, Mainz/Germany

Christoph Huber
CIMT, Mainz/Germany